About Lisa Foster

Articles by Lisa Foster

$Glofitamab (Columvi) to Treat Relapsed or Refractory DLBCL image$

Glofitamab (Columvi) to Treat Relapsed or Refractory DLBCL
May 20, 2024
$Gemtuzumab Ozogamicin for Relapsed/Refractory AML image$

Gemtuzumab Ozogamicin for Relapsed/Refractory AML
May 16, 2024
DLBCL Treatment Patterns & Outcomes: A Real-World Look at DLBCL Treatment
May 13, 2024
Vadadustat: A New Option for Managing Anemia in Chronic Kidney Disease on Dialysis
May 13, 2024
Eltrombopag: A Treatment for Low Platelets in MDS
May 09, 2024
Treg Cells in AML: The Immune System's Double-Edged Sword
May 08, 2024
New Ways To Treat Fatigue in CLL
May 07, 2024
Ensuring Access to Myeloma Research, with Dr. Gurbakhash Kaur
May 07, 2024
DLBCL in Adolescents and Young Adults (AYA)
May 06, 2024
$The FDA Is Reviewing A New Treatment Option For Relapsed/Refractory AML image$

The FDA Is Reviewing A New Treatment Option For Relapsed/Refractory AML
May 01, 2024
Is There A Cure For DLBCL?
Apr 29, 2024
Brentuximab Vedotin Combo Shows Improvement in DLBCL Survival
Apr 25, 2024
Real World Myeloma Research with Adeel Khan, MD, UT Southwestern
Apr 24, 2024
How CAR-T Therapy is Changing the Treatment Landscape for Myeloma
Apr 18, 2024
Tazemetostat as a New Therapy for Follicular Lymphoma with the EZH2 Mutation
Apr 18, 2024
Living Beyond DLBCL: Minimizing Cardiovascular Risks
Apr 17, 2024
For Newly Diagnosed: Setting Up Your Expectations For Having Myeloma
Apr 17, 2024
What Is MGRS And How Does It Affect My Kidneys?
Apr 10, 2024
What Is The Myeloma Coach Program?
Apr 01, 2024
CAR T-cell Therapy for Follicular Lymphoma
Apr 01, 2024
What Are JAK Inhibitors and How Do They Help Treat Myelofibrosis?
Apr 01, 2024
What Is APOL1-Mediated Kidney Disease (AMKD)?
Mar 25, 2024
The Effective Use Of Homoharringtonine In Pediatric AML
Mar 19, 2024
What Is Prefibrotic Myelofibrosis?
Mar 19, 2024